• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内益生菌补充与胆固醇稳态的关系。

Cholesterol homeostasis associated with probiotic supplementation in vivo.

机构信息

Faculty of Applied Sciences, Tunku Abdul Rahman University College, Kuala Lumpur, Malaysia.

Institute of Biosience, Universiti Putra Malaysia, Selangor, Malaysia.

出版信息

J Appl Microbiol. 2020 Nov;129(5):1374-1388. doi: 10.1111/jam.14678. Epub 2020 Jun 10.

DOI:10.1111/jam.14678
PMID:32356362
Abstract

AIMS

To determine the mechanism underlying the serum cholesterol reduction effect by probiotics isolated from local fermented tapioca (Tapai).

METHODS AND RESULTS

Lactic acid bacteria strains were isolated and examined for acid tolerance, bile salt resistance and hypocholesterolemic properties. Among the isolates, Lactobacillus plantarum TAR4 showed the highest cholesterol reduction ability (48·01%). The focus in the in vivo trial was to elucidate the cholesterol balance from findings pertaining to serum cholesterol reduction in rat model fed with high fat diet via oral administration. Rats fed with high-cholesterol diet supplemented with Lact. plantarum TAR4 showed significant reduction in serum total cholesterol (29·55%), serum triglyceride (45·31%) and liver triglyceride (23·44%) as compared to high-cholesterol diet (HCD) group. There was a significant increment in faecal triglyceride (45·83%) and faecal total bile acid (384·95%) as compared to HCD group.

CONCLUSIONS

The findings showed that probiotic Lact. plantarum TAR4 supplementation reduced the absorption of bile acids for enterohepatic recycling and increased the catabolism of cholesterol to bile acids and not by suppressing the rate of cholesterol synthesis.

SIGNIFICANCE AND IMPACT OF STUDY

Probiotic supplements could provide a new nonpharmacological alternative to reduce cardiovascular risk factors.

摘要

目的

确定从当地发酵木薯(Tapioca)中分离出的益生菌降低血清胆固醇的作用机制。

方法和结果

分离并检测了乳酸菌的耐酸性、耐胆盐性和降胆固醇特性。在分离株中,植物乳杆菌 TAR4 显示出最高的胆固醇降低能力(48.01%)。在体内试验中,重点是通过口服高胆固醇饮食的大鼠模型来阐明胆固醇平衡,从血清胆固醇降低的发现中得出结论。与高胆固醇饮食(HCD)组相比,补充植物乳杆菌 TAR4 的大鼠血清总胆固醇(29.55%)、血清甘油三酯(45.31%)和肝甘油三酯(23.44%)显著降低。与 HCD 组相比,粪便甘油三酯(45.83%)和粪便总胆汁酸(384.95%)显著增加。

结论

研究结果表明,益生菌植物乳杆菌 TAR4 的补充减少了胆汁酸的吸收,以进行肠肝循环,并增加了胆固醇向胆汁酸的代谢,而不是通过抑制胆固醇合成的速度。

研究的意义和影响

益生菌补充剂可能为降低心血管危险因素提供一种新的非药物替代方法。

相似文献

1
Cholesterol homeostasis associated with probiotic supplementation in vivo.体内益生菌补充与胆固醇稳态的关系。
J Appl Microbiol. 2020 Nov;129(5):1374-1388. doi: 10.1111/jam.14678. Epub 2020 Jun 10.
2
Probiotic characteristics of Lactobacillus plantarum E680 and its effect on Hypercholesterolemic mice.植物乳杆菌 E680 的益生菌特性及其对高胆固醇血症小鼠的影响。
BMC Microbiol. 2020 Aug 4;20(1):239. doi: 10.1186/s12866-020-01922-4.
3
Lactobacillus plantarum strains as potential probiotic cultures with cholesterol-lowering activity.植物乳杆菌菌株作为具有降胆固醇活性的潜在益生菌培养物。
J Dairy Sci. 2013 May;96(5):2746-53. doi: 10.3168/jds.2012-6123. Epub 2013 Mar 15.
4
Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet.两种乳酸杆菌菌株对高胆固醇饮食大鼠脂代谢和肠道微生物的影响。
BMC Complement Altern Med. 2011 Jul 3;11:53. doi: 10.1186/1472-6882-11-53.
5
Influence of a cholesterol-lowering strain LP3 isolated from traditional fermented yak milk on gut bacterial microbiota and metabolome of rats fed with a high-fat diet.降脂菌株 LP3 对高脂饮食大鼠肠道菌群和代谢组的影响,该菌株分离自传统发酵牦牛乳。
Food Funct. 2020 Sep 23;11(9):8342-8353. doi: 10.1039/d0fo01939a.
6
Identification of a Novel Potential Probiotic Lactobacillus plantarum FB003 Isolated from Salted-Fermented Shrimp and its Effect on Cholesterol Absorption by Regulation of NPC1L1 and PPARα.从盐渍虾中分离出的新型潜在益生菌植物乳杆菌 FB003 的鉴定及其通过调节 NPC1L1 和 PPARα 对胆固醇吸收的影响。
Probiotics Antimicrob Proteins. 2019 Sep;11(3):785-793. doi: 10.1007/s12602-018-9469-9.
7
In vitro cholesterol-lowering properties of Lactobacillus plantarum AN6 isolated from aji-narezushi.从 aji-narezushi 中分离的植物乳杆菌 AN6 的体外降胆固醇特性。
Lett Appl Microbiol. 2013 Sep;57(3):187-92. doi: 10.1111/lam.12094. Epub 2013 May 20.
8
Selection of potential probiotic lactobacilli for cholesterol-lowering properties and their effect on cholesterol metabolism in rats fed a high-lipid diet.选择具有降胆固醇特性的潜在益生菌乳杆菌及其对高脂饮食喂养大鼠胆固醇代谢的影响。
J Dairy Sci. 2012 Apr;95(4):1645-54. doi: 10.3168/jds.2011-4768.
9
Screening for Cholesterol-Lowering Probiotics from Lactic Acid Bacteria Isolated from Corn Silage Based on Three Hypothesized Pathways.基于三条假设途径从玉米青贮中分离的乳酸菌中筛选降胆固醇益生菌。
Int J Mol Sci. 2019 Apr 26;20(9):2073. doi: 10.3390/ijms20092073.
10
The protective mechanism of Lactobacillus plantarum FZU3013 against non-alcoholic fatty liver associated with hyperlipidemia in mice fed a high-fat diet.高脂饮食诱导的非酒精性脂肪性肝病及其伴随的血脂异常中植物乳杆菌 FZU3013 的保护机制。
Food Funct. 2020 Apr 30;11(4):3316-3331. doi: 10.1039/c9fo03003d.

引用本文的文献

1
Weissella confusa MW051433 Mitigates Hypercholesterolemia by Biliary Cholesterol Excretion: The In Vivo Evidence.混淆魏斯氏菌MW051433通过胆汁胆固醇排泄减轻高胆固醇血症:体内证据
Curr Microbiol. 2025 Apr 1;82(5):222. doi: 10.1007/s00284-025-04173-6.
2
Enhancing Gut Microbiome and Metabolic Health in Mice Through Administration of Presumptive Probiotic Strain PE11.通过施用推定益生菌菌株PE11改善小鼠肠道微生物群和代谢健康
Nutrients. 2025 Jan 25;17(3):442. doi: 10.3390/nu17030442.
3
The efficacy of Lacticaseibacillus paracasei MSMC39-1 and Bifidobacterium animalis TA-1 probiotics in modulating gut microbiota and reducing the risk of the characteristics of metabolic syndrome: A randomized, double-blinded, placebo-controlled study.
副干酪乳杆菌MSMC39-1和动物双歧杆菌TA-1益生菌在调节肠道微生物群及降低代谢综合征特征风险方面的功效:一项随机、双盲、安慰剂对照研究。
PLoS One. 2025 Jan 10;20(1):e0317202. doi: 10.1371/journal.pone.0317202. eCollection 2025.
4
N4 ameliorates lipid metabolism and gut microbiota structure in high fat diet-fed rats.N4改善高脂饮食喂养大鼠的脂质代谢和肠道微生物群结构。
Front Microbiol. 2024 Jun 7;15:1390293. doi: 10.3389/fmicb.2024.1390293. eCollection 2024.
5
exopolysaccharides: new insights into engineering strategies, physicochemical functions, and immunomodulatory effects on host health.胞外多糖:工程策略、物理化学功能及对宿主健康的免疫调节作用的新见解
Front Microbiol. 2024 May 6;15:1396308. doi: 10.3389/fmicb.2024.1396308. eCollection 2024.
6
Potential probiotic Lactobacillus delbrueckii subsp. lactis KUMS-Y33 suppresses adipogenesis and promotes osteogenesis in human adipose-derived mesenchymal stem cell.潜在的益生菌德氏乳杆菌乳酸亚种KUMS-Y33可抑制人脂肪间充质干细胞的脂肪生成并促进其成骨作用。
Sci Rep. 2024 Apr 27;14(1):9689. doi: 10.1038/s41598-024-60061-2.
7
Investigating the Efficacy of in Metabolic Syndrome Treatment: A Narrative Review of What Is Known So Far.探讨 治疗代谢综合征的疗效:迄今为止已知内容的叙述性综述。
Int J Mol Sci. 2023 Jul 27;24(15):12015. doi: 10.3390/ijms241512015.
8
Effect of fermented milk BK01 on cholesterol and microbiota in Wistar mice intestine.发酵乳BK01对Wistar小鼠肠道胆固醇及微生物群的影响。
J Adv Vet Anim Res. 2023 Mar 31;10(1):64-71. doi: 10.5455/javar.2023.j653. eCollection 2023 Mar.
9
Impact of Feeding Probiotics on Blood Parameters, Tail Fat Metabolites, and Volatile Flavor Components of Sunit Sheep.饲喂益生菌对苏尼特羊血液参数、尾脂代谢产物及挥发性风味成分的影响
Foods. 2022 Aug 31;11(17):2644. doi: 10.3390/foods11172644.
10
The Activity of Prebiotics and Probiotics in Hepatogastrointestinal Disorders and Diseases Associated with Metabolic Syndrome.益生菌和益生元在肝胆胃肠疾病及代谢综合征相关疾病中的作用。
Int J Mol Sci. 2022 Jun 29;23(13):7229. doi: 10.3390/ijms23137229.